A budding new approach strengthens an important message

In vaccinology, both mRNA-based delivery of genes encoding antigens as well as nanoparticle-based vaccines have shown great promise in tackling challenging pathogens. In this issue of Cell, Hoffmann et al. combine these two approaches, harnessing the same cellular pathway hijacked by many viruses to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zost, Seth J., Carnahan, Robert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210232/
https://www.ncbi.nlm.nih.gov/pubmed/37236153
http://dx.doi.org/10.1016/j.cell.2023.04.034
_version_ 1785047025551671296
author Zost, Seth J.
Carnahan, Robert H.
author_facet Zost, Seth J.
Carnahan, Robert H.
author_sort Zost, Seth J.
collection PubMed
description In vaccinology, both mRNA-based delivery of genes encoding antigens as well as nanoparticle-based vaccines have shown great promise in tackling challenging pathogens. In this issue of Cell, Hoffmann et al. combine these two approaches, harnessing the same cellular pathway hijacked by many viruses to boost immune responses to SARS-CoV-2 vaccination.
format Online
Article
Text
id pubmed-10210232
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-102102322023-05-25 A budding new approach strengthens an important message Zost, Seth J. Carnahan, Robert H. Cell Preview In vaccinology, both mRNA-based delivery of genes encoding antigens as well as nanoparticle-based vaccines have shown great promise in tackling challenging pathogens. In this issue of Cell, Hoffmann et al. combine these two approaches, harnessing the same cellular pathway hijacked by many viruses to boost immune responses to SARS-CoV-2 vaccination. Elsevier Inc. 2023-05-25 2023-05-25 /pmc/articles/PMC10210232/ /pubmed/37236153 http://dx.doi.org/10.1016/j.cell.2023.04.034 Text en © 2023 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Preview
Zost, Seth J.
Carnahan, Robert H.
A budding new approach strengthens an important message
title A budding new approach strengthens an important message
title_full A budding new approach strengthens an important message
title_fullStr A budding new approach strengthens an important message
title_full_unstemmed A budding new approach strengthens an important message
title_short A budding new approach strengthens an important message
title_sort budding new approach strengthens an important message
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210232/
https://www.ncbi.nlm.nih.gov/pubmed/37236153
http://dx.doi.org/10.1016/j.cell.2023.04.034
work_keys_str_mv AT zostsethj abuddingnewapproachstrengthensanimportantmessage
AT carnahanroberth abuddingnewapproachstrengthensanimportantmessage
AT zostsethj buddingnewapproachstrengthensanimportantmessage
AT carnahanroberth buddingnewapproachstrengthensanimportantmessage

Ejemplares similares